Hanlin Gao - Mar 1, 2024 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Chief Scientific Officer
Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Mar 1, 2024
Transactions value $
-$22,589
Form type
4
Date filed
3/5/2024, 04:26 PM
Previous filing
Feb 28, 2024
Next filing
Apr 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Tax liability -$16.4K -704 -0.08% $23.24 929K Mar 1, 2024 Direct F1
transaction FLGT Common Stock Tax liability -$6.23K -268 -0.03% $23.24 929K Mar 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.